Michael Baker, Chief Executive Officer & Managing Director at Arovella Therapeutics Limited, holds 6.57M shares in Arovella Therapeutics Limited (Ticker: AU:ALA). Most recently, Michael Baker Bought AU$220,000 shares of Arovella Therapeutics Limited on Mar 27, 2024 for an estimated value of 31.28K.
What is the percentage of profitable transactions made by Michael Baker?
The percentage of profitable transactions made by Michael Baker is 57%.
What is the average return per transaction made by Michael Baker?
The average return per transaction made by Michael Baker is 39.30%.
What stocks does Michael Baker hold?
Michael Baker holds: AU:ALA stocks.
What was Michael Baker’s latest transaction?
Michael Baker latest transaction was an Informative Buy of AU$31.28K.
What was Michael Baker's most profitable transaction?
Michael Baker’s most profitable transaction was an Informative Buy of AU:ALA stock on July 12, 2023. The return on the trade was 216.60%.
What is Michael Baker's role in Arovella Therapeutics Limited?
Michael Baker's role in Arovella Therapeutics Limited is Chief Executive Officer & Managing Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.